Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$320M |
| 2 |
Gilead Sciences
GILD
|
+$266M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$213M |
| 4 |
TE Connectivity
TEL
|
+$179M |
| 5 |
Merck
MRK
|
+$179M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SHPG
Shire pic
SHPG
|
+$211M |
| 2 |
CNVR
CONVERSANT INC COM STK (DE)
CNVR
|
+$117M |
| 3 |
EOG Resources
EOG
|
+$106M |
| 4 |
CNQR
CONCUR TECHNOLOGIES INC
CNQR
|
+$102M |
| 5 |
CPWR
COMPUWARE CORP
CPWR
|
+$99.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.47% |
| 2 | Technology | 14.75% |
| 3 | Financials | 11.98% |
| 4 | Industrials | 9.42% |
| 5 | Consumer Discretionary | 7.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Hancock Whitney
HWC
$6.01B
| $273K | ﹤0.01% |
8,900
-4,192
| -32% | -$136K |
|
2152
Watts Water Technologies
WTS
$12.4B
| $273K | ﹤0.01% |
4,300
| – | – |
|
|
PHLT
2153
DELISTED
Performant Healthcare Inc
PHLT
| $272K | ﹤0.01% |
40,910
-8,190
| -17% | -$59.9K |
|
|
UAM
2154
DELISTED
Universal American Corp
UAM
| $271K | ﹤0.01% |
29,200
-417
| -1% | -$3.63K |
|
|
KAMN
2155
DELISTED
Kaman Corp
KAMN
| $269K | ﹤0.01% |
6,700
+307
| +5% | +$12.3K |
|
|
CTP
2156
DELISTED
CTPARTNERS EXECUTIVE SEARCH INC (DE)
CTP
| $269K | ﹤0.01% |
+17,700
| New | +$309K |
|
2157
Center Bancorp
CNOB
$1.62B
| $268K | ﹤0.01% |
14,100
-1,400
| -9% | -$26K |
|
2158
Forward Air
FWRD
$594M
| $267K | ﹤0.01% |
5,300
| – | – |
|
|
GRX
2159
Gabelli Healthcare & Wellness Trust
GRX
$150M
| $266K | ﹤0.01% |
+25,518
| New | +$260K |
|
2160
Martin Marietta Materials
MLM
$32B
| $265K | ﹤0.01% |
+2,400
| New | +$284K |
|
|
SF
2161
Stifel
SF
$12.2B
| $265K | ﹤0.01% |
11,700
-38
| -0.3% | -$804 |
|
2162
Unitil
UTL
$977M
| $264K | ﹤0.01% |
7,200
+606
| +9% | +$21.1K |
|
|
ARTX
2163
DELISTED
Arotech Corporation
ARTX
| $263K | ﹤0.01% |
113,500
-5,000
| -4% | -$13K |
|
|
OMED
2164
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $263K | ﹤0.01% |
+12,100
| New | +$248K |
|
2165
SouthState Bank Corp
SSB
$10.4B
| $262K | ﹤0.01% |
3,900
-1,100
| -22% | -$67.5K |
|
|
PGNX
2166
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $262K | ﹤0.01% |
+34,600
| New | +$207K |
|
|
TAX
2167
DELISTED
Liberty Tax, Inc. Class A
TAX
| $261K | ﹤0.01% |
+7,300
| New | +$265K |
|
2168
Choice Hotels
CHH
$5B
| $259K | ﹤0.01% |
4,619
-1,664
| -26% | -$89.4K |
|
2169
Myers Industries
MYE
$1.26B
| $259K | ﹤0.01% |
14,730
-31,196
| -68% | -$505K |
|
|
ALOG
2170
DELISTED
Analogic Corp
ALOG
| $259K | ﹤0.01% |
3,062
-2,900
| -49% | -$218K |
|
|
LIOX
2171
DELISTED
Lionbridge Technologies
LIOX
| $259K | ﹤0.01% |
45,100
-7,700
| -15% | -$38.7K |
|
2172
McGrath RentCorp
MGRC
$2.85B
| $258K | ﹤0.01% |
7,183
-1,200
| -14% | -$42.7K |
|
2173
VSE Corp
VSEC
$6.03B
| $257K | ﹤0.01% |
+7,800
| New | +$218K |
|
2174
DHT Holdings
DHT
$3.18B
| $256K | ﹤0.01% |
+35,000
| New | +$222K |
|
2175
Greenlight Captial
GLRE
$507M
| $256K | ﹤0.01% |
+7,843
| New | +$253K |
|
Similar funds
Cliff Asness's Q4 2014 Portfolio in Review
As of Q4 2014, Cliff Asness held 2,816 positions worth $47.8B, up 31% from $36.4B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Cliff Asness deployed $7.61B of net new capital in Q4 2014, opening 319 new positions and adding to 937 existing holdings. Its largest new stake was LyondellBasell Industries: 3,695,296 shares worth $293M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was EOG Resources, an estimated $106M trimmed.
- Cliff Asness's largest Q4 2014 buy was LyondellBasell Industries: 3,695,296 shares worth $293M.
- Cliff Asness added most to Gilead Sciences in Q4 2014, an estimated $266M increase.
- Cliff Asness's biggest Q4 2014 reduction was EOG Resources, cutting an estimated $106M.
- Cliff Asness fully exited Shire pic in Q4 2014, selling an estimated $211M.
- Cliff Asness's ten largest holdings make up 9.3% of its $47.8B portfolio in Q4 2014.
- Cliff Asness opened 319 new positions and closed 310 in Q4 2014.
- Cliff Asness's portfolio value rose 31% quarter-over-quarter to $47.8B.
Based on AQR Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.